Prescription medicine

Nystatin and triamcinolone

Nystatin and triamcinolone is a prescription medicine. FDA's NDC Directory lists it from 18 generic labelers, and pharmacies paid $0.225 per gram (Nystatin-triamcinolone cream) in the October 7, 2026 NADAC survey.

Generic listed

Check it at the source: the nystatin and triamcinolone FDA label on DailyMed (effective January 12, 2026, Crown Laboratories); every nystatin and triamcinolone label on DailyMed.

Highlights of the record

FDA label of January 12, 2026; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026; NADAC October 7, 2026

Used for

From the label: indications and usage
Nystatin and Triamcinolone Acetonide Cream is indicated for the treatment of cutaneous candidiasis;

Forms and strengths

1 mg/g

Cream; ointment.

On the market

Generic approvals: 35 first May 1, 1985; 18 with a marketed status in Drugs@FDA
Labelers listed (NDC): 18 of which 18 under generic applications, 0 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC): $0.225 per gram Nystatin-triamcinolone cream
Shortage (FDA): No current entry
Recalls by its makers (FDA): 4 since 2017 0 Class I among all firms' recalls; latest March 15, 2022
FAERS reports: 108 through July 30, 2026

What is nystatin and triamcinolone used for?

From the label: indications and usage
Nystatin and Triamcinolone Acetonide Cream is indicated for the treatment of cutaneous candidiasis; it has been demonstrated that the nystatin-steroid combination provides greater benefit than the nystatin component alone during the first few days of treatment.

Conditions named in the indications of nystatin and triamcinolone's FDA labels, with every medicine labeled for each:

Fungal infections

From other nystatin and triamcinolone labels
Fungal infections: INDICATIONS AND USAGE Nystatin and Triamcinolone Acetonide Cream is indicated for the treatment of cutaneous candidiasis; it has been demonstrated that the nystatin-steroid combination provides greater benefit than the nystatin component …

FDA pharmacologic class: Corticosteroid and Polyene Antifungal.

Source: FDA drug label (Nystatin and Triamcinolone Acetonide), Crown Laboratories, effective January 12, 2026 (SPL set 54aae5d3-e482-4da0-a1b2-0ed70e6c2915), via openFDA; the full label on DailyMed

Is there a generic for nystatin and triamcinolone?

The FDA approved the first generic nystatin and triamcinolone on May 1, 1985. 35 generic applications are approved; 18 of them carry a current (not discontinued) marketing status in Drugs@FDA; that status is not evidence that the generic is on sale.

FDA's NDC Directory lists nystatin and triamcinolone from 18 labelers under a generic (ANDA) application. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it.

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What do pharmacies pay for nystatin and triamcinolone?

In CMS's NADAC survey of October 7, 2026, pharmacies paid $0.225 per gram (Nystatin-triamcinolone cream), down 16% from $0.267 on October 8, 2025. The chart's scale runs from the lowest to the highest price shown, not from zero. NADAC is what retail pharmacies paid their wholesalers, per unit, in CMS's monthly survey; what a patient pays depends on insurance and the pharmacy.

Nystatin-triamcinolone cream (generic)

$0.453

$0.205

January 2024October 2026

NADAC per unit, October 7, 2026
Strength and form	Brand or generic	Pharmacy cost	30 tablets, or one pen or vial	12-month change
Nystatin-triamcinolone cream	Generic	$0.225 per gram	n/a	-16%
Nystatin-triamcinolone ointm	Generic	$0.265 per gram	n/a	-7%
Nystatin-triamcinolone ointment	Generic	$0.265 per gram	n/a	-7%

Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price

Has nystatin and triamcinolone been recalled?

The FDA's Enforcement Report lists 4 recalls naming nystatin and triamcinolone since 2017: 0 Class I (the most serious), 3 Class II, 1 Class III; 0 still ongoing. A recall names products and lots, not every product of the medicine.

Started	Class	Company	Reason
March 15, 2022	Class II	Teligent Pharma, Inc.	cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
July 17, 2019	Class III	Lupin Pharmaceuticals Inc.	Failed Content Uniformity Specifications: Out-of-specification result observed in uniformity of containers test at 9 month long term stability condition for …
September 21, 2018	Class II	Dr. Reddy's Laboratories, Inc.	Failed stability specifications - An out of specification result was observed for the test parameter : composition of Nystatin during stability testing.
March 28, 2017	Class II	Taro Pharmaceuticals U.S.A., Inc.	Failed Content Uniformity Specifications; out-of-specification (OOS) results 18-month stability

Source: FDA Enforcement Report (drug recalls) via openFDA, through October 8, 2026

What do FAERS reports show for nystatin and triamcinolone?

The FDA Adverse Event Reporting System holds 108 reports that list nystatin and triamcinolone among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 0 are coded as a death and 6 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

The most reported reactions

Drug Ineffective (a use or a product term, not a reaction)23
Product Use In Unapproved Indication (a use or a product term, not a reaction)11
Application Site Pain8
Pruritus8
Drug Ineffective For Unapproved Indication (a use or a product term, not a reaction)6
Diarrhoea5
Off Label Use (a use or a product term, not a reaction)5
Pain5

Side effects: the label's list and every FAERS reaction

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What else is labeled for the same conditions as nystatin and triamcinolone?

18 other medicines are given the same way (topical) and in the same FDA class as nystatin and triamcinolone or labeled mainly for the same use (fungal infections), the same class first. Fungal infections lists all 33 medicines labeled for it, by any route. The first 8 are below. They are listed as records, not as substitutes: whether one can replace another is a prescriber's decision.

Medicine	Shared indication	Generic labelers (topical)	Pharmacy cost	Shortage
Betamethasone and clotrimazole	Fungal infections	16 labelers	$0.190 per gram Clotrimazole-betamethasone cream	No current entry
Tolnaftate	Fungal infections	none listed	$0.119 per gram 1% cream	No current entry
Clotrimazole	Fungal infections	13 labelers	$0.133 per gram 1% topical cream	No current entry
Miconazole	Fungal infections	none listed	$0.120 per gram 2% topical cream	No current entry
Undecylenic acid	Fungal infections	none listed	n/a	No current entry
Ketoconazole	Fungal infections	25 labelers	$0.249 per gram 2% cream	No current entry
Selenium sulfide	Fungal infections	1 labeler	$0.0141 per mL 1% shampoo	No current entry
Ciclopirox	Fungal infections	14 labelers	$0.169 per gram 0.77% cream	No current entry

Every medicine labeled for the same conditions as nystatin and triamcinolone

Source: FDA drug labels (indications), NDC Directory, NADAC of October 7, 2026, FDA shortages (October 8, 2026)

What next?

Alternatives to nystatin and triamcinolone: 18 medicines for the same use
Other corticosteroids: the pharmacologic class, with prices and generics
Nystatin and triamcinolone side effects: the label's list beside FAERS reports
Check an interaction: what two or more labels say about each other